Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041701 | SCV000065397 | benign | not specified | 2009-06-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000041701 | SCV000169762 | benign | not specified | 2014-01-30 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000041701 | SCV000707026 | benign | not specified | 2017-03-21 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000993536 | SCV001146595 | benign | not provided | 2018-09-12 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000993536 | SCV001156940 | benign | not provided | 2023-10-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000993536 | SCV001719828 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000041701 | SCV002051056 | likely benign | not specified | 2021-12-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000993536 | SCV003916552 | benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | USH2A: BP4, BS1, BS2 |
Genome- |
RCV003450751 | SCV004182089 | likely benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001271133 | SCV004182090 | likely benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003887884 | SCV004707859 | benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Breakthrough Genomics, |
RCV000993536 | SCV005261744 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001271133 | SCV001451985 | benign | Usher syndrome type 2A | 2020-09-16 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000993536 | SCV001744667 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000041701 | SCV001953630 | benign | not specified | no assertion criteria provided | clinical testing |